He is to be the chair of the combined entity!
US Listing is beneficial to AKE shareholders only if there is a premium attached to it. No longer the case and in fact being tied to Livent is a millstone around AKE's neck.
Under current pricing having a hydroxide plant in the US weighs down Livent's own non-conversion earnings. HYdroxide prices are similar to Carbonate and in China, and at times prices at a discount to Carbonate. What expertise do they bring to the table that AKE with a commissioned Naraha doesn't already have?
At current market prices, there is NO shortage of buyers for AKE's current or future production. AKE has a proven track record for some years now and we do not need Tesla to lend us any credibility ( not intended as a slight to Tesla ).
Signed off by a bunch of stupid shareholders
- Forums
- ASX - By Stock
- AKE
- Merger: Yes or No
Merger: Yes or No, page-59
-
-
- There are more pages in this discussion • 1,007 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AKE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online